Evidence map›Paper›PMID 41900938›Full record

ReviewLife (Basel, Switzerland)2026

Prognostic Stratification in Primary Glomerulonephritis: Integrating Histology, Biomarkers, and Risk Prediction Models.

Andreea Simona Covic, Adrian Covic, Irina Draga Caruntu, Lucian Siriteanu, Mehmet Kanbay, Gener Ismail, Luminița Voroneanu, Mihai Onofriescu

Abstract readReview
In one paragraph

Review in Life (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Andreea Simona CovicDepartment of Nephrology, "Grigore T. Popa" University of Medicine and Pharmacy, 700115 Iași, Romania.
Adrian CovicDepartment of Nephrology, "Grigore T. Popa" University of Medicine and Pharmacy, 700115 Iași, Romania.ORCID 0000-0002-9985-2486
Irina Draga Caruntu"Dr. C. I. Parhon" University Hospital, 700503 Iași, Romania.
Lucian SiriteanuDepartment of Nephrology, "Grigore T. Popa" University of Medicine and Pharmacy, 700115 Iași, Romania.
Mehmet KanbayDepartment of Medicine, Division of Nephrology, Koc University School of Medicine Istanbul, Sarıyer 34450, Turkey.ORCID 0000-0002-1297-0675
Gener IsmailDepartment of Nephrology, "Carol Davila" University of Medicine and Pharmacy, 050474 Bucharest, Romania.
Luminița VoroneanuDepartment of Nephrology, "Grigore T. Popa" University of Medicine and Pharmacy, 700115 Iași, Romania.
Mihai OnofriescuDepartment of Nephrology, "Grigore T. Popa" University of Medicine and Pharmacy, 700115 Iași, Romania.ORCID 0000-0002-1780-6284

Funding

"Grigore T. Popa" University of Medicine and Pharmacy Iasi, Romania IDEI-ECHIPE, 2025 competition
6 · The paper itself

Abstract

Primary glomerulonephritis encompasses a diverse group of kidney diseases with variable clinical trajectories and outcomes. Accurate prognostic stratification is critical for guiding individualized management and improving long-term renal survival. This narrative review synthesizes current evidence on the prognostic value of histological grading systems, circulating and urinary biomarkers, and integrative risk prediction models across major primary glomerulonephritis subtypes, including IgA nephropathy, membranous nephropathy, and focal segmental glomerulosclerosis. Emphasis is placed on the utility of established classification systems (e.g., Oxford, MEST-C, chronicity scores), emerging tissue and fluid biomarkers (e.g., PLA2R antibodies, complement components, cytokine profiles), and the validation of multivariable prognostic tools and nomograms. We highlight areas of convergence between histopathologic lesions and molecular markers, as well as the evolving role of machine learning in predictive modeling. Ultimately, combining morphological, biochemical, and algorithmic tools holds promise for precision risk assessment and treatment tailoring in primary glomerulonephritis.

Indexed as

histologic scoring systemsprimary glomerulonephritisprognostic biomarkersrenal outcomerisk prediction models

Identifiers

PMID41900938
PMCPMC13027879

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.